Doses of PCV7
|
Doses of PHiD-CV10
| |
---|
0
|
1
|
2
|
3
|
4
|
TOTAL
|
---|
0
|
33e
|
18 e
|
50
|
284
|
77
|
411
|
1
|
5 e
|
2 e
|
23
|
16
|
1
|
40
|
2
|
28
|
15
|
30 e
| | |
43
|
3
|
322
|
73
|
1 e
| | |
395¥
|
4
|
5
|
1
| | | |
6
|
+ PPV23§
|
138§
| | | | | |
+ PCV13¥
|
2¥
|
0
|
19¥
|
70¥
|
1¥
|
92¥
|
TOTAL
|
355
|
89
|
73
|
300
|
78
|
895
|
- PCV7, 7-valent pneumococcal conjugate vaccine.
- PHiD-CV10, 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine.
- PCV13, 13-valent pneumococcal conjugate vaccine.
- Included mixed schedules:
-
§138 children also received one dose PPV23: (ceased in October 2010) 138 of 177 PCV7 3-dose children who were age-eligible for PPV23.
-
¥92 children also received one dose PCV13:
- 2 of 322 PCV7 3-dose children.
- 19 of 50 PHiD-CV10 2-dose children.
- 70 of 284 PHiD-CV10 3-dose children.
- 1 of 77 PHiD-CV10 4-dose child.
- Excluded schedules
-
e91 children were excluded, including two additional children (not shown in Table 2) who received two doses of PHiD-CV10 and two doses of PCV13.